The Link Between the Microbiota and HER2+ Breast Cancer: The New Challenge of Precision Medicine

The microbiota is emerging as a key player in cancer due to its involvement in several host physiological functions, including digestion, development of the immune system, and modulation of endocrine function. Moreover, its participation in the efficacy of anticancer treatments has been well described. For instance, the involvement of the breast microbiota in breast cancer (BC) development and progression has gained ground in the past several years. In this review, we report and discuss new findings on the impact of the gut and breast microbiota on BC, focusing on the HER2+ BC subtype, and the possibility of defining microbial signatures that are associated with disease aggressiveness, treatment response, and therapy toxicity. We also discuss novel insights into the mechanisms through which microorganism-host interactions occur and the possibility of microbiota editing in the prevention and treatment optimization of BC.

Abstract licence: CC BY

1. 2.

   Local bacteria affect the efficacy of chemotherapeutic drugs · 2015

2. 9.

   Microbial Dysbiosis Is Associated with Human Breast Cancer · 2014

3. 44.

   The Microbiome of Aseptically Collected Human Breast Tissue in Benign and Malignant Disease · 2016

4. 45.

   The Microbiota of Breast Tissue and Its Association with Breast Cancer · 2016

5. 52.

   Lithocholic acid controls adaptive immune responses by inhibition of Th1 activation through the Vitamin D receptor · 2017

6. 54.

   Breast tissue, oral and urinary microbiomes in breast cancer · 2017

7. 55.

   Sodium butyrate promotes apoptosis in breast cancer cells through reactive oxygen species (ROS) formation and mitochondrial impairment · 2017

8. 58.

   A comprehensive analysis of breast cancer microbiota and host gene expression · 2017

9. 73.

   Cadaverine, a metabolite of the microbiome, reduces breast cancer aggressiveness through trace amino acid receptors · 2019

10. 75.
    Corrected

    Short Chain Fatty Acids (SCFAs)-Mediated Gut Epithelial and Immune Regulation and Its Relevance for Inflammatory Bowel Diseases · 2019

11. 80.

    Wnt/β-Catenin Signaling as a Molecular Target by Pathogenic Bacteria · 2019

12. 92.

    Breast cancer colonization by Fusobacterium nucleatum accelerates tumor growth and metastatic progression · 2020

13. 96.

    Breast and Gut Microbiota Action Mechanisms in Breast Cancer Pathogenesis and Treatment · 2020

14. 106.

    Anti-cancer and anti-inflammatory effects elicited by short chain fatty acids produced by Escherichia coli isolated from healthy human gut microbiota · 2021

15. 110.

    Human breast microbiome correlates with prognostic features and immunological signatures in breast cancer · 2021

16. 111.

    Corrigendum: Short Chain Fatty Acids (SCFAs)-Mediated Gut Epithelial and Immune Regulation and Its Relevance for Inflammatory Bowel Diseases · 2019

17. 112.

    Intestinal microbiota influences clinical outcome and side effects of early breast cancer treatment · 2021

114 more references, whose wording the paper’s licence keeps private.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.